Elsevier Inc.

SHERPA: Unknown

People

  1. Kernan
    Kernan
  2. Scaradavou
    Scaradavou
  3. Kobos
    Kobos
  4. O'Reilly
    O'Reilly
  5. Zakak
    Zakak
  6. Curran
    Curran
  7. Ruggiero
    Ruggiero
  8. Papadopoulos
    Papadopoulos
  9. Abboud
    Abboud
  10. Casson
    Casson

Groups

  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Nursing (11)
  4. Pediatrics, Department of (11)
  5. Stem Cell Transplantation and Cellular Therapy Service (11)
  6. Advanced Practice Providers (9)
  7. Hematologic Malignancies, Division of (8)
  8. Bone Marrow Transplant (7)
  9. GSK Faculty (6)
  10. Immunology Program Faculty (6)
Search Within
  1. "Andromachi Scaradavou"
  2. "Nancy Kernan"
  3. "Nursing"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (3)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Nursing (11)
  4. Pediatrics, Department of (11)
  5. Stem Cell Transplantation and Cellular Therapy Service (11)
  6. Advanced Practice Providers (9)

More Groups

People
  1. Andromachi Scaradavou (11)
  2. Nancy Kernan (11)
  3. Susan Prockop (7)
  4. Farid Boulad (6)
  5. Juliet Barker (6)
  6. Rachel Kobos (6)

More People

Years
  1. 2019 (1)
  2. 2016 (2)
  3. 2015 (2)
  4. 2014 (2)
  5. 2012 (1)
  6. 2011 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • T- cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic GVHD and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (< 21 years) with AML in CR1
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Wolden, S.; Curran, K. J.; Hasan, A. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Double unit cord blood transplantation (dCBT) progression-free survival (PFS) is unaffected by grade III-IV acute graft-versus-Host disease (aGVHD) and survivors are likely to discontinue immunosuppression (IS) and reconstitute T-cells
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Yoo, Y.; Lauer, E.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies
    Journal Article

    Shah, G. L.; Shune, L.; Purtill, D.; Devlin, S.; Lauer, E.; Lubin, M.; Bhatt, V.; McElrath, C.; Kernan, N. A.; Scaradavou, A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • High disease-free survival (DFS) supports continued investigation of double-unit cord blood transplantation (DCBT) in children with high-risk acute leukemia especially in the setting of single units with low dose and/or a high degree of HLA-mismatch
    Meeting Abstract

    Scaradavou, A.; Lubin, M.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Third party donor derived EBV specific T cells for the treatment of refractory EBV-related post-transplant lymphomas
    Meeting Abstract

    Prockop, S. E.; Doubrovina, E. S.; Barker, J. N.; Baroudy, K.; Boulad, F.; Kernan, N. A.; Khalaf, R.; Kobos, R.; Papadopoulos, E.; Sauter, C.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation (HSCT) for non malignant hematologic disorders (NMHD), using a chemotherapy-only cytoreductive regimen and T-cell depleted grafts from alternative donors
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Lehrman, R.; Ruggiero, J. M.; Curran, K.; Kobos, R.; O'reilly, R.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Safety and effectiveness of intravenous palivizumab for prevention of respiratory syncytial virus infection following allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Small, T. N.; Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Kobos, R.; Zakak, N.; Ruggiero, J.; O'Reilly, R. J.
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)
    Journal Article

    Chou, J. F.; Kernan, N. A.; Prockop, S.; Heller, G.; Scaradavou, A.; Kobos, R.; Knowles, M. A.; Papadopoulos, E. B.; Casson, A.; Copeland, C.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation
    Journal Article

    Scaradavou, A.; Smith, K. M.; Hawke, R.; Schaible, A.; Abboud, M.; Kernan, N. A.; Young, J. W.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save